Cargando…

Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study

BACKGROUND: People Who Use Drugs (PWUD) have lower vaccination uptake than the general population, and disproportionately experience the burden of harms from vaccine-preventable diseases. We conducted a national qualitative study to: (1) identify the barriers and facilitators to receiving COVID-19 v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Farihah, Kaura, Ashima, Russell, Cayley, Bonn, Matthew, Bruneau, Julie, Dasgupta, Nabarun, Imtiaz, Sameer, Martel-Laferrière, Valérie, Rehm, Jürgen, Shahin, Rita, Elton-Marshall, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387201/ https://www.ncbi.nlm.nih.gov/pubmed/37516836 http://dx.doi.org/10.1186/s12954-023-00826-6

Ejemplares similares

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data
por: Imtiaz, Sameer, et al.
Publicado: (2021)

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2021)

Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse
por: Ali, Farihah, et al.
Publicado: (2022)

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada
por: Ali, Farihah, et al.
Publicado: (2021)

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
por: Russell, Cayley, et al.
Publicado: (2021)

Corrigendum to “Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study” [Journal of Substance Abuse Treatment 129 (2021) 108374]
por: Russell, Cayley, et al.
Publicado: (2021)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
por: Russell, Cayley, et al.
Publicado: (2023)

“2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit
por: Ali, Farihah, et al.
Publicado: (2023)

Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study
por: Ali, Farihah, et al.
Publicado: (2023)

Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020
por: Imtiaz, Sameer, et al.
Publicado: (2022)

The impact of prescription opioids on all-cause mortality in Canada
por: Imtiaz, Sameer, et al.
Publicado: (2016)

Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2019)

Recent changes in trends of opioid overdose deaths in North America
por: Imtiaz, Sameer, et al.
Publicado: (2020)

Patients Followed in an Addiction Medicine Clinic Are Less Likely to Be Eligible to Hepatitis C Drug Studies Regardless of Drug Use
por: Doré, Gabrielle, et al.
Publicado: (2017)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
por: Russell, Cayley, et al.
Publicado: (2022)

Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
por: Saeed, Sahar, et al.
Publicado: (2017)

Vibrio cholerae in Traveler from Haiti to Canada
por: Gilmour, Matthew W., et al.
Publicado: (2011)

A narrative review of alcohol consumption as a risk factor for global burden of disease
por: Rehm, Jürgen, et al.
Publicado: (2016)

Changes in Alcohol Consumption in Canada During the COVID-19 Pandemic: Associations With Anxiety and Self-Perception of Depression and Loneliness
por: Shield, Kevin D, et al.
Publicado: (2021)

Assessing service and treatment needs of young people who use illicit and non-medical prescription drugs living in Northern Ontario, Canada
por: Varatharajan, Thepikaa, et al.
Publicado: (2019)

Guidance on take-home naloxone distribution and use by community overdose responders in Canada
por: Ferguson, Max, et al.
Publicado: (2023)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada
por: Palayew, Adam, et al.
Publicado: (2021)

Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs
por: Martel-Laferrière, Valérie, et al.
Publicado: (2022)

Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005
por: Shield, Kevin D, et al.
Publicado: (2012)

Harms of prescription opioid use in the United States
por: Imtiaz, Sameer, et al.
Publicado: (2014)

Quantifying the global contribution of alcohol consumption to cardiomyopathy
por: Manthey, Jakob, et al.
Publicado: (2017)

Determining the sex-specific distributions of average daily alcohol consumption using cluster analysis: is there a separate distribution for people with alcohol dependence?
por: Jiang, Huan, et al.
Publicado: (2021)

Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review
por: Khan, Amal, et al.
Publicado: (2023)

Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada
por: Wiese, Jessica L., et al.
Publicado: (2022)

Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis
por: Somé, Nibene Habib, et al.
Publicado: (2022)

Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada
por: Ferguson, Max, et al.
Publicado: (2023)

Trends and uptake of new formulations of controlled‐release oxycodone in Canada
por: Gomes, Tara, et al.
Publicado: (2018)

850. Reasons for not Using PrEP and Actions that May Facilitate PrEP Uptake in Ontario and British Columbia, Canada
por: Espinosa, Oscar Javier Pico, et al.
Publicado: (2021)

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy
por: Martel-Laferrière, Valérie, et al.
Publicado: (2014)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

Types of suicide pacts: a comparative analysis using the National Violent Death Reporting System
por: Kim, Kawon Victoria, et al.
Publicado: (2023)

Maternal alcohol use, adverse neonatal outcomes and pregnancy complications in British Columbia, Canada: a population-based study
por: Popova, Svetlana, et al.
Publicado: (2021)

The Devil Is in the Details! On Regulating Cannabis Use in Canada Based on Public Health Criteria: Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts"
por: Rehm, Jürgen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_99svse1udq0ennclknmdccpii2